REUTERS
June 26, 2020 at 17:39 JST
A vaccine volunteer receives an injection at the Chris Hani Baragwanath hospital in Soweto, Johannesburg on June 24. (AP Photo)
Daiichi Sankyo Co. is in discussions to provide supplies of a potential coronavirus vaccine now being developed by AstraZeneca Plc and the University of Oxford for use in Japan.
In a statement, Daiichi Sankyo said on Friday one of its subsidiaries would receive undiluted solution of the vaccine and then carry out formulation procedures, packaging and storage in Japan. AstraZeneca said separately that it is in talks with the Japanese government on supplies of the potential vaccine, known as AZD1222.
Chief Cabinet Secretary Yoshihide Suga said earlier on Friday that the government is supporting domestic vaccine development but is also in negotiations with other parties.
“In any event, the government will work hard to ensure that Japan has the vaccines it needs,” Suga said.
In Japan, AnGes Inc. and Osaka University are working on a DNA vaccine for the novel coronavirus. Shionogi & Co. is working on a recombinant protein type, while the University of Tokyo and Daiichi Sankyo are developing an mRNA version.
Stories about memories of cherry blossoms solicited from readers
Cooking experts, chefs and others involved in the field of food introduce their special recipes intertwined with their paths in life.
A series based on diplomatic documents declassified by Japan’s Foreign Ministry
A series on the death of a Japanese woman that sparked a debate about criminal justice policy in the United States
A series about Japanese-Americans and their memories of World War II
Here is a collection of first-hand accounts by “hibakusha” atomic bomb survivors.